Clinical Trials Directory

Trials / Unknown

UnknownNCT02814032

Proteomics of Papillary Thyroid Carcinoma

Differences Protein Expression in Papillary Thyroid Carcinoma

Status
Unknown
Phase
Study type
Observational
Enrollment
32 (estimated)
Sponsor
The Affiliated Hospital of Inner Mongolia Medical University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Thyroid carcinoma is the common endocrine system malignant neoplasm. At present it has become the malignant neoplasm of fastest growing incidence rate. More than 85% thyroid carcinoma is papillary thyroid carcinoma. Cervical lymph node metastasis is common in papillary thyroid carcinoma patients. This study aim to reveal protein expression differences between papillary thyroid carcinoma with cervical lymph node metastasis and without cervical lymph node metastasis.

Detailed description

1. Object: Patients aged 18-65 years; newly diagnosed papillary thyroid carcinoma with cervical lymph node metastasis and without cervical lymph node metastasis and undergone thyroidectomy according to the China thyroid association guidelines for the Management of thyroid nodule and thyroid cancer. 2. Clinical information, examination data: Information is obtained from medical record abstraction. 3. Samples: Fresh frozen thyroid tissues from each sample group(normal histology, benign disease, papillary thyroid carcinoma with cervical lymph node metastasis, papillary thyroid carcinoma without cervical lymph node metastasis ).

Conditions

Timeline

Start date
2016-06-01
Primary completion
2023-12-01
Completion
2024-06-01
First posted
2016-06-27
Last updated
2023-07-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02814032. Inclusion in this directory is not an endorsement.